Works matching IS 18607179 AND DT 2021 AND VI 16 AND IP 11
Results: 15
Front Cover: E7766, a Macrocycle‐Bridged Stimulator of Interferon Genes (STING) Agonist with Potent Pan‐Genotypic Activity (ChemMedChem 11/2021).
- Published in:
- ChemMedChem, 2021, v. 16, n. 11, p. 1680, doi. 10.1002/cmdc.202100346
- By:
- Publication type:
- Article
Thiazolidinediones: An In–Depth Study of Their Synthesis and Application to Medicinal Chemistry in the Treatment of Diabetes Mellitus.
- Published in:
- ChemMedChem, 2021, v. 16, n. 11, p. 1716, doi. 10.1002/cmdc.202100177
- By:
- Publication type:
- Article
Hydroxypyridinethione Inhibitors of Human Insulin‐Degrading Enzyme.
- Published in:
- ChemMedChem, 2021, v. 16, n. 11, p. 1775, doi. 10.1002/cmdc.202100111
- By:
- Publication type:
- Article
E7766, a Macrocycle‐Bridged Stimulator of Interferon Genes (STING) Agonist with Potent Pan‐Genotypic Activity.
- Published in:
- ChemMedChem, 2021, v. 16, n. 11, p. 1740, doi. 10.1002/cmdc.202100068
- By:
- Publication type:
- Article
Cyclopentadienyl‐Based Anticancer Drugs: Improvement of Cytotoxic Activity through Functionalisation of the π Ligand.
- Published in:
- ChemMedChem, 2021, v. 16, n. 11, p. 1804, doi. 10.1002/cmdc.202100060
- By:
- Publication type:
- Article
Using Theory To Extend the Scope of Azobenzene Drugs in Chemotherapy: Novel Combinations for a Specific Delivery.
- Published in:
- ChemMedChem, 2021, v. 16, n. 11, p. 1764, doi. 10.1002/cmdc.202100046
- By:
- Publication type:
- Article
The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Phenotypic Drug Discovery.
- Published in:
- ChemMedChem, 2021, v. 16, n. 11, p. 1736, doi. 10.1002/cmdc.202100041
- By:
- Publication type:
- Article
Strategies towards Targeting Gαi/s Proteins: Scanning of Protein‐Protein Interaction Sites To Overcome Inaccessibility.
- Published in:
- ChemMedChem, 2021, v. 16, n. 11, p. 1696, doi. 10.1002/cmdc.202100039
- By:
- Publication type:
- Article
Synthesis of Triphenylethylene‐Naphthalimide Conjugates as topoisomerase‐IIα inhibitor and HSA binder.
- Published in:
- ChemMedChem, 2021, v. 16, n. 11, p. 1821, doi. 10.1002/cmdc.202100034
- By:
- Publication type:
- Article
A "Golden Age" for the discovery of new antileishmanial agents: Current status of leishmanicidal gold complexes and prospective targets beyond the trypanothione system.
- Published in:
- ChemMedChem, 2021, v. 16, n. 11, p. 1681, doi. 10.1002/cmdc.202100022
- By:
- Publication type:
- Article
Drimane Derivatives as the First Examples of Covalent BH3 Mimetics that Target MCL‐1.
- Published in:
- ChemMedChem, 2021, v. 16, n. 11, p. 1788, doi. 10.1002/cmdc.202100011
- By:
- Publication type:
- Article
Oxa Analogues of Nexturastat A Demonstrate Improved HDAC6 Selectivity and Superior Antileukaemia Activity.
- Published in:
- ChemMedChem, 2021, v. 16, n. 11, p. 1798, doi. 10.1002/cmdc.202001011
- By:
- Publication type:
- Article
The Acid/Base Characterization of Molecules with Epigenetic Activity.
- Published in:
- ChemMedChem, 2021, v. 16, n. 11, p. 1744, doi. 10.1002/cmdc.202001009
- By:
- Publication type:
- Article
Development of a High‐Affinity Antibody‐Binding Peptide for Site‐Specific Modification.
- Published in:
- ChemMedChem, 2021, v. 16, n. 11, p. 1813, doi. 10.1002/cmdc.202000977
- By:
- Publication type:
- Article
Assessment of CYP2C9 Structural Models for Site of Metabolism Prediction.
- Published in:
- ChemMedChem, 2021, v. 16, n. 11, p. 1754, doi. 10.1002/cmdc.202000964
- By:
- Publication type:
- Article